Owners of Nemera, a medical device maker, are exploring a potential sale following increased demand for GLP-1 drug delivery systems.
Owners of Nemera, a medical device manufacturer, are exploring a sale amid a surge in demand for GLP-1 drug delivery systems. The company has not provided further details on timing or potential buyers.
Further verified specifics about the process were not immediately available.
Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
More from Priya Anand →
